ResMed Inc (BSP:R1MD34)
R$ 371.16 0 (0%) Market Cap: 217.94 Bil Enterprise Value: 220.49 Bil PE Ratio: 33.02 PB Ratio: 7.04 GF Score: 85/100

Resmed Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 04:10PM GMT
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Good morning. It's Matt Miksic, medical device analyst -- U.S. medical device analyst. I'm glad to welcome and introduce Rob Douglas, COO of ResMed, who will go through a presentation and if there's time permitting, we'll have some Q&A at the end of the presentation. But Rob, thanks very much for joining us.

Robert A. Douglas
ResMed Inc. - President & COO

Thanks, Matt. Okay. Thank you. I'm going to give a quick overview of ResMed and of our strategy and a quick recap of recent performance. At the end, there should be some time for questions. So I'm happy to take questions from the audience, as we go through.

So I just skipped over the safe harbor there. Now in terms of ResMed, who are we? We are the leading connected health care company in the world. And I'll explain a little more how this works. But we have the largest network of connected medical devices in the world. And we are using the data that we generate from that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot